The overall goal of the proposed revision is to develop a Neuroimaging Core in the Rush Alzheimer?s Disease Core Center (Rush ADCC) that will build a resource of neuroimaging data from the Rush ADCC African Americans and Latinos and from ancillary studies, and will provide neuroimaging expertise to facilitate high quality, cutting edge, externally funded research focusing on the transition from normal aging to mild cognitive impairment (MCI) to the earliest stages of Alzheimer?s disease (AD) and other dementias. Specifically, the Neuroimaging Core will collect high quality, multi-modal, longitudinal in-vivo brain magnetic resonance imaging (MRI) data from African American and Latino participants of the Clinical and Latino Cores who agree to autopsy, and will integrate the new data along with a large volume of in-vivo and ex-vivo MRI data from separately funded studies, all based on state-of-the-art, uniform data acquisition protocols. The Neuroimaging Core will perform thorough quality checks and detailed processing of the in-vivo and ex-vivo MRI data in the database to generate rich output on the macro-structural, micro-structural, chemical, and functional characteristics of the older adult brain. The proposed Neuroimaging Core will build upon strengths of the Rush ADCC including A) longitudinal clinical assessment of persons who enroll without dementia, B) longitudinal ante-mortem biofluid collection, and C) post-mortem biospecimen collection from large numbers of persons, many without dementia. The Neuroimaging Core of the Rush ADCC will widely distribute all brain MRI data and processing results to investigators within and outside of the Rush ADCC, and will provide neuroimaging expertise in support of research efforts in normal aging, cognitive decline, mild cognitive impairment, AD and related dementias. The contributions of the Neuroimaging Core will stimulate research that A) develops novel imaging biomarkers of age-related neuropathologies and molecular genetics generated from human brain and blood from the same persons, B) elucidates brain mechanisms supporting cognitive and motor health or leading to decline, C) evaluates the effects of risk factors on the brain, and D) ascertains the role of various brain characteristics in racial/ethnic disparities of cognitive aging related outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-30
Application #
9977097
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Yu, Lei; Petyuk, Vladislav A; Gaiteri, Chris et al. (2018) Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol 84:78-88
Jansen, Willemijn J; Wilson, Robert S; Visser, Pieter Jelle et al. (2018) Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 61:138-145
Benedet, Andréa L; Yu, Lei; Labbe, Aurélie et al. (2018) CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet 4:e216
Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93
Arvanitakis, Zoe; Leurgans, Sue E; Fleischman, Debra A et al. (2018) Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 83:718-729
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Wilson, Robert S; Capuano, Ana W; Yu, Lei et al. (2018) Neurodegenerative disease and cognitive retest learning. Neurobiol Aging 66:122-130
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 786 publications